Barr and Mylan launch Razadyne generics in US – update
This article was originally published in Scrip
Executive Summary
Barr Pharmaceuticalsand Mylanhave launched the first US generics of Johnson & Johnson's Razadyne (galantamine hydrobromide) tablets for Alzheimer's dementia following a federal court ruling invalidating the innovator's patent.